These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2886540)

  • 1. A search for endogenous Na+,K+-ATPase inhibitor in acutely volume-expanded hog plasma led to lysophosphatidylcholine gamma-stearoyl.
    Tamura M; Inagami T; Kinoshita T; Kuwano H
    J Hypertens; 1987 Apr; 5(2):219-25. PubMed ID: 2886540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.
    Tamura M; Harris TM; Higashimori K; Sweetman BJ; Blair IA; Inagami T
    Biochemistry; 1987 May; 26(10):2797-806. PubMed ID: 3038164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Na+,K+-ATPase inhibitors of volume-expanded hog plasma.
    Inagami T; Tamura M
    Hypertension; 1987 Nov; 10(5 Pt 2):I108-12. PubMed ID: 2824359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume-expanded hog plasma.
    Tamura M; Kuwano H; Kinoshita T; Inagami T
    J Biol Chem; 1985 Aug; 260(17):9672-7. PubMed ID: 2991258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human erythrocyte and leukocyte Na+, K(+)-pump activity by lysophosphatidylcholines.
    Lijnen P; Huysecom J; Fagard R; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):281-6. PubMed ID: 2374475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
    Tal DM; Yanuck MD; van Hall G; Karlish SJ
    Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifications induced by plasma from insulin-dependent diabetic patients and by lysophosphatidylcholine on human Na+,K(+)-adenosine triphosphatase.
    Rabini RA; Fumelli P; Zolese G; Amler E; Salvolini E; Staffolani R; Cester N; Mazzanti L
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2405-10. PubMed ID: 9661619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
    Yasuhara T; Mori M; Wakamatsu K; Kubo K
    Biochem Biophys Res Commun; 1991 Jul; 178(1):95-103. PubMed ID: 1648917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of peripheral venous response to volume expansion in borderline systemic hypertension.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    Am J Cardiol; 1990 Sep; 66(5):597-602. PubMed ID: 2144096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ; Baecker A; Weiler E; Liddiard C
    Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
    Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
    Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC; Weiler EW; Prins BA; Purdy RE
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
    Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, purification and partial characterization of a 70kDa inhibitor protein of Na(+)/K(+)-ATPase from cytosol of pulmonary artery smooth muscle.
    Dey K; Chakraborti T; Roy S; Ghosh B; Kar P; Chakraborti S
    Life Sci; 2010 Mar; 86(13-14):473-81. PubMed ID: 20149805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma inhibitors of Na,K-ATPase: relation to salt balance and hypertension.
    Buckalew VM; Morris M; Campbell WG; Rauch AL
    Klin Wochenschr; 1987; 65 Suppl 8():133-8. PubMed ID: 3599798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.